Health News Summary: Uganda braces for Ebola, Beef products recalled and more

Following is a summary of current health news briefs.

Uganda to deploy Ebola vaccine if virus spreads from Congo

Uganda will vaccinate against Ebola should it spread from Democratic Republic of Congo, which has been hit twice this year, the World Health Organization (WHO) said on Thursday. Uganda borders Congo's Ituri and North Kivu provinces, where Ebola is believed to have killed 97 people since the latest outbreak started in July, and infected another 45.

Cargill recalls about 132,000 lbs of beef products over possible contamination

Cargill Meat Solutions is recalling about 132,000 pounds of ground beef products that may have been contaminated with E.Coli, the U.S. Department of Agriculture said on Wednesday. Cargill's ground beef had been identified in an August investigation into an E.Coli outbreak which had resulted in 17 illnesses and one death, the USDA's Food Safety and Inspection Service (FSIS) said in a statement.

More evidence exercise may be good for your mood

People who exercise may experience symptoms of mental health disorders less often, a U.S. study suggests. That may be true even when the exercise involves doing household chores, researchers found.

Takeda lung cancer drug gets European panel nod

Takeda Pharmaceutical Co's lung cancer drug received the recommendation of a European Union panel on Friday, more than a year after it won regulatory approval to be sold in the United States. The European Medicines Agency's Committee for Medicinal Products for Human Use, recommended granting Japan-based Takeda's Alunbrig, or brigatinib, a marketing authorization.

One in three gun-owning U.S. veterans don't store weapons safely

A substantial percentage of U.S. military vets store guns loaded and ready to use, according to an American study that could have implications for suicide prevention. "American veterans have a higher suicide risk than demographically matched U.S. adults and most of their suicides are actually related to firearm injury," said lead author Dr. Joseph Simonetti of the Denver Veterans Affairs Medical Center in Colorado.

Bon appetit! French find traces of bugs in their food and drink

From insect residues in fizzy drinks to beef gelatin in yoghurt, consumer group Foodwatch said it had found undisclosed animal-based ingredients in a dozen food and drink products sold in France. The watchdog's findings come as consumers call for more transparency on the ingredients in their food, and as the number of vegans and vegetarians rises in France."All kinds of critters are hiding in our food and drink without us knowing it," Foodwatch said in a statement published on Thursday denouncing "scams on the label".

Excess pounds can lead to a leaky bladder

Young and middle-aged women who are overweight or obese may be more likely to develop a leaky bladder, researchers say. Australian researchers found that obese women were twice as likely as those at normal weight to leak urine, according to a paper in Obesity Reviews.

China reports first case of African swine fever Jilin province

China reported two new cases of African swine fever on Friday, as the deadly disease continued to spread to new areas in the world's top pork producer. One case occurred on a farm of 484 pigs in the city of Gongzhuling in Jilin province in the northeast of China, killing 56 pigs, said the Ministry of Agriculture and Rural Affairs. This is the first outbreak of the disease in the province.

Lilly migraine drug wins European panel thumbs-up

A European Medicines Agency panel on Friday recommended the approval of U.S. pharmaceutical group Eli Lilly's migraine treatment, bringing the drug one step closer to being sold in the European Union. Emgality, or galcanezumab, which treats episodic cluster headache attacks, was endorsed by the Committee for Medicinal Products for Human Use, a panel whose recommendations are generally followed by European regulators.

Bayer hemophilia treatment wins thumbs-up from EU panel

Bayer AG's long-acting treatment for hemophilia A has won a recommendation from a European Medicines Agency (EMA) panel for the treatment of the rare genetic disorder in which blood does not clot easily. While final approvals are up to the European Commission, it generally follows recommendations from the Committee for Medicinal Products for Human Use (CHMP) and endorses them within a couple of months.